PMO Interview with the Innovator Series: Volume 6
Lawrence M. Weiss, MD
Video Categories: PMO Interview with the Innovator Series
Dr. Sanjiv Agarwala analyzes anti-PD-1 and anti-PD-L1 therapies in terms what they do and their unique toxicities and response patterns.
Alexander Bastian says the most important thing to come out of ASH that will improve standard of care is the variety of treatments coming available, including a new drug from Amgen for treating ALL.